Synthesis and Pharmacological Characterization of 3-[2-((3aR,9bR)-cis-6-Methoxy- 2,3,3a,4,5,9b-hexahydro-1H- benz[e]isoindol-2-yl)ethyl]pyrido[3‘,4‘:4,5]thieno[3,2-d]pyrimidine- 2,4(1H,3H)-dione (A-131701):  A Uroselective α1A Adrenoceptor Antagonist for the Symptomatic Treatment of Benign Prostatic Hyperplasia

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medicinal chemistry 1997-09, Vol.40 (20), p.3141-3143
Hauptverfasser: Meyer, Michael D, Altenbach, Robert J, Basha, Fatima Z, Carroll, William A, Drizin, Irene, Elmore, Steven W, Ehrlich, Paul P, Lebold, Suzanne A, Tietje, Karin, Sippy, Kevin B, Wendt, Michael D, Plata, Daniel J, Plagge, Fred, Buckner, Steven A, Brune, Michael E, Hancock, Arthur A, Kerwin, James F
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3143
container_issue 20
container_start_page 3141
container_title Journal of medicinal chemistry
container_volume 40
creator Meyer, Michael D
Altenbach, Robert J
Basha, Fatima Z
Carroll, William A
Drizin, Irene
Elmore, Steven W
Ehrlich, Paul P
Lebold, Suzanne A
Tietje, Karin
Sippy, Kevin B
Wendt, Michael D
Plata, Daniel J
Plagge, Fred
Buckner, Steven A
Brune, Michael E
Hancock, Arthur A
Kerwin, James F
description
doi_str_mv 10.1021/jm970364a
format Article
fullrecord <record><control><sourceid>acs_pasca</sourceid><recordid>TN_cdi_pascalfrancis_primary_2833128</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>c391881881</sourcerecordid><originalsourceid>FETCH-LOGICAL-a978-445149f7b736dfe714aec45f4808cb3c4449e0cfd749399bb6e521aeb41ee00c3</originalsourceid><addsrcrecordid>eNo9Uk2O0zAYDQgkysCCG3gBUivF4L80zWxQp2IoYoAyLQKpqiLH-dK4JHbkBNTMarbcgGtwEQ4xJ8GdotnY-vyen_3e9wXBM0peUsLoq12dxISPhbwfDGjECBYTIh4EA0IYw2zM-KPgcdvuCCGcMj6493rZm66EVrdImhwtSulqqWxlt1rJCs18LVUHTl_JTluDbIE4XjM8HHJ5GSbZ5Qgr3eIx_gBdafc9RizkIZehCCMP4xL2suxzZzGdY5SBuVrDRrdWm9xWmOG-GvmLfbVpeqdzu-Y3179D4ZdTL7DpSg3GH4YM57eMWufawOERMaTzkM9HOPffAjScYsppTOjo9Ob6F5qiL862UIHq9E9Af__QKZrmzospaDrr0NR0cmuNbjtU-NJHgJZ97aHa-1Ro5UB2NZjuYPgMjN4atPCK3S067xtwTSVbLZ8EDwtZtfD0_34SrM7frGZzfPHp7bvZ9ALLJJ5gISIqkiLOYj7OC4ipkKBEVPjmTFTGlRAiAaKKPBYJT5IsG0PEqIRMUABCFD8Jnh9lG9n6vhROGh972vhEpOtTNuG-nRNPw0ea9wX7O1i67-k45nGUrhbL9PO36Ozr5P15-tHzXxz5UrXpzv5wxntIKUkPs5TezRL_B1WTvXE</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Synthesis and Pharmacological Characterization of 3-[2-((3aR,9bR)-cis-6-Methoxy- 2,3,3a,4,5,9b-hexahydro-1H- benz[e]isoindol-2-yl)ethyl]pyrido[3‘,4‘:4,5]thieno[3,2-d]pyrimidine- 2,4(1H,3H)-dione (A-131701):  A Uroselective α1A Adrenoceptor Antagonist for the Symptomatic Treatment of Benign Prostatic Hyperplasia</title><source>ACS Publications</source><creator>Meyer, Michael D ; Altenbach, Robert J ; Basha, Fatima Z ; Carroll, William A ; Drizin, Irene ; Elmore, Steven W ; Ehrlich, Paul P ; Lebold, Suzanne A ; Tietje, Karin ; Sippy, Kevin B ; Wendt, Michael D ; Plata, Daniel J ; Plagge, Fred ; Buckner, Steven A ; Brune, Michael E ; Hancock, Arthur A ; Kerwin, James F</creator><creatorcontrib>Meyer, Michael D ; Altenbach, Robert J ; Basha, Fatima Z ; Carroll, William A ; Drizin, Irene ; Elmore, Steven W ; Ehrlich, Paul P ; Lebold, Suzanne A ; Tietje, Karin ; Sippy, Kevin B ; Wendt, Michael D ; Plata, Daniel J ; Plagge, Fred ; Buckner, Steven A ; Brune, Michael E ; Hancock, Arthur A ; Kerwin, James F</creatorcontrib><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm970364a</identifier><identifier>CODEN: JMCMAR</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>Biological and medical sciences ; Medical sciences ; Pharmacology. Drug treatments ; Urinary system</subject><ispartof>Journal of medicinal chemistry, 1997-09, Vol.40 (20), p.3141-3143</ispartof><rights>Copyright © 1997 American Chemical Society</rights><rights>1997 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/jm970364a$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/jm970364a$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,776,780,27053,27901,27902,56713,56763</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2833128$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>Meyer, Michael D</creatorcontrib><creatorcontrib>Altenbach, Robert J</creatorcontrib><creatorcontrib>Basha, Fatima Z</creatorcontrib><creatorcontrib>Carroll, William A</creatorcontrib><creatorcontrib>Drizin, Irene</creatorcontrib><creatorcontrib>Elmore, Steven W</creatorcontrib><creatorcontrib>Ehrlich, Paul P</creatorcontrib><creatorcontrib>Lebold, Suzanne A</creatorcontrib><creatorcontrib>Tietje, Karin</creatorcontrib><creatorcontrib>Sippy, Kevin B</creatorcontrib><creatorcontrib>Wendt, Michael D</creatorcontrib><creatorcontrib>Plata, Daniel J</creatorcontrib><creatorcontrib>Plagge, Fred</creatorcontrib><creatorcontrib>Buckner, Steven A</creatorcontrib><creatorcontrib>Brune, Michael E</creatorcontrib><creatorcontrib>Hancock, Arthur A</creatorcontrib><creatorcontrib>Kerwin, James F</creatorcontrib><title>Synthesis and Pharmacological Characterization of 3-[2-((3aR,9bR)-cis-6-Methoxy- 2,3,3a,4,5,9b-hexahydro-1H- benz[e]isoindol-2-yl)ethyl]pyrido[3‘,4‘:4,5]thieno[3,2-d]pyrimidine- 2,4(1H,3H)-dione (A-131701):  A Uroselective α1A Adrenoceptor Antagonist for the Symptomatic Treatment of Benign Prostatic Hyperplasia</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><subject>Biological and medical sciences</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Urinary system</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><recordid>eNo9Uk2O0zAYDQgkysCCG3gBUivF4L80zWxQp2IoYoAyLQKpqiLH-dK4JHbkBNTMarbcgGtwEQ4xJ8GdotnY-vyen_3e9wXBM0peUsLoq12dxISPhbwfDGjECBYTIh4EA0IYw2zM-KPgcdvuCCGcMj6493rZm66EVrdImhwtSulqqWxlt1rJCs18LVUHTl_JTluDbIE4XjM8HHJ5GSbZ5Qgr3eIx_gBdafc9RizkIZehCCMP4xL2suxzZzGdY5SBuVrDRrdWm9xWmOG-GvmLfbVpeqdzu-Y3179D4ZdTL7DpSg3GH4YM57eMWufawOERMaTzkM9HOPffAjScYsppTOjo9Ob6F5qiL862UIHq9E9Af__QKZrmzospaDrr0NR0cmuNbjtU-NJHgJZ97aHa-1Ro5UB2NZjuYPgMjN4atPCK3S067xtwTSVbLZ8EDwtZtfD0_34SrM7frGZzfPHp7bvZ9ALLJJ5gISIqkiLOYj7OC4ipkKBEVPjmTFTGlRAiAaKKPBYJT5IsG0PEqIRMUABCFD8Jnh9lG9n6vhROGh972vhEpOtTNuG-nRNPw0ea9wX7O1i67-k45nGUrhbL9PO36Ozr5P15-tHzXxz5UrXpzv5wxntIKUkPs5TezRL_B1WTvXE</recordid><startdate>19970926</startdate><enddate>19970926</enddate><creator>Meyer, Michael D</creator><creator>Altenbach, Robert J</creator><creator>Basha, Fatima Z</creator><creator>Carroll, William A</creator><creator>Drizin, Irene</creator><creator>Elmore, Steven W</creator><creator>Ehrlich, Paul P</creator><creator>Lebold, Suzanne A</creator><creator>Tietje, Karin</creator><creator>Sippy, Kevin B</creator><creator>Wendt, Michael D</creator><creator>Plata, Daniel J</creator><creator>Plagge, Fred</creator><creator>Buckner, Steven A</creator><creator>Brune, Michael E</creator><creator>Hancock, Arthur A</creator><creator>Kerwin, James F</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>IQODW</scope></search><sort><creationdate>19970926</creationdate><title>Synthesis and Pharmacological Characterization of 3-[2-((3aR,9bR)-cis-6-Methoxy- 2,3,3a,4,5,9b-hexahydro-1H- benz[e]isoindol-2-yl)ethyl]pyrido[3‘,4‘:4,5]thieno[3,2-d]pyrimidine- 2,4(1H,3H)-dione (A-131701):  A Uroselective α1A Adrenoceptor Antagonist for the Symptomatic Treatment of Benign Prostatic Hyperplasia</title><author>Meyer, Michael D ; Altenbach, Robert J ; Basha, Fatima Z ; Carroll, William A ; Drizin, Irene ; Elmore, Steven W ; Ehrlich, Paul P ; Lebold, Suzanne A ; Tietje, Karin ; Sippy, Kevin B ; Wendt, Michael D ; Plata, Daniel J ; Plagge, Fred ; Buckner, Steven A ; Brune, Michael E ; Hancock, Arthur A ; Kerwin, James F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a978-445149f7b736dfe714aec45f4808cb3c4449e0cfd749399bb6e521aeb41ee00c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Biological and medical sciences</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Urinary system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Meyer, Michael D</creatorcontrib><creatorcontrib>Altenbach, Robert J</creatorcontrib><creatorcontrib>Basha, Fatima Z</creatorcontrib><creatorcontrib>Carroll, William A</creatorcontrib><creatorcontrib>Drizin, Irene</creatorcontrib><creatorcontrib>Elmore, Steven W</creatorcontrib><creatorcontrib>Ehrlich, Paul P</creatorcontrib><creatorcontrib>Lebold, Suzanne A</creatorcontrib><creatorcontrib>Tietje, Karin</creatorcontrib><creatorcontrib>Sippy, Kevin B</creatorcontrib><creatorcontrib>Wendt, Michael D</creatorcontrib><creatorcontrib>Plata, Daniel J</creatorcontrib><creatorcontrib>Plagge, Fred</creatorcontrib><creatorcontrib>Buckner, Steven A</creatorcontrib><creatorcontrib>Brune, Michael E</creatorcontrib><creatorcontrib>Hancock, Arthur A</creatorcontrib><creatorcontrib>Kerwin, James F</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Meyer, Michael D</au><au>Altenbach, Robert J</au><au>Basha, Fatima Z</au><au>Carroll, William A</au><au>Drizin, Irene</au><au>Elmore, Steven W</au><au>Ehrlich, Paul P</au><au>Lebold, Suzanne A</au><au>Tietje, Karin</au><au>Sippy, Kevin B</au><au>Wendt, Michael D</au><au>Plata, Daniel J</au><au>Plagge, Fred</au><au>Buckner, Steven A</au><au>Brune, Michael E</au><au>Hancock, Arthur A</au><au>Kerwin, James F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis and Pharmacological Characterization of 3-[2-((3aR,9bR)-cis-6-Methoxy- 2,3,3a,4,5,9b-hexahydro-1H- benz[e]isoindol-2-yl)ethyl]pyrido[3‘,4‘:4,5]thieno[3,2-d]pyrimidine- 2,4(1H,3H)-dione (A-131701):  A Uroselective α1A Adrenoceptor Antagonist for the Symptomatic Treatment of Benign Prostatic Hyperplasia</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>1997-09-26</date><risdate>1997</risdate><volume>40</volume><issue>20</issue><spage>3141</spage><epage>3143</epage><pages>3141-3143</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><coden>JMCMAR</coden><cop>Washington, DC</cop><pub>American Chemical Society</pub><doi>10.1021/jm970364a</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 1997-09, Vol.40 (20), p.3141-3143
issn 0022-2623
1520-4804
language eng
recordid cdi_pascalfrancis_primary_2833128
source ACS Publications
subjects Biological and medical sciences
Medical sciences
Pharmacology. Drug treatments
Urinary system
title Synthesis and Pharmacological Characterization of 3-[2-((3aR,9bR)-cis-6-Methoxy- 2,3,3a,4,5,9b-hexahydro-1H- benz[e]isoindol-2-yl)ethyl]pyrido[3‘,4‘:4,5]thieno[3,2-d]pyrimidine- 2,4(1H,3H)-dione (A-131701):  A Uroselective α1A Adrenoceptor Antagonist for the Symptomatic Treatment of Benign Prostatic Hyperplasia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T06%3A39%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-acs_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20and%20Pharmacological%20Characterization%20of%203-%5B2-((3aR,9bR)-cis-6-Methoxy-%202,3,3a,4,5,9b-hexahydro-1H-%20benz%5Be%5Disoindol-2-yl)ethyl%5Dpyrido%5B3%E2%80%98,4%E2%80%98:4,5%5Dthieno%5B3,2-d%5Dpyrimidine-%202,4(1H,3H)-dione%20(A-131701):%E2%80%89%20A%20Uroselective%20%CE%B11A%20Adrenoceptor%20Antagonist%20for%20the%20Symptomatic%20Treatment%20of%20Benign%20Prostatic%20Hyperplasia&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Meyer,%20Michael%20D&rft.date=1997-09-26&rft.volume=40&rft.issue=20&rft.spage=3141&rft.epage=3143&rft.pages=3141-3143&rft.issn=0022-2623&rft.eissn=1520-4804&rft.coden=JMCMAR&rft_id=info:doi/10.1021/jm970364a&rft_dat=%3Cacs_pasca%3Ec391881881%3C/acs_pasca%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true